Biotechnology Company
Appears in 1 story
Competitor developing allogeneic CAR-T; ALLO-715 myeloma program on FDA clinical hold
Every approved cancer cell therapy today requires extracting a patient's own cells, engineering them in a lab, and infusing them back. It costs over $400,000 and sometimes takes weeks — long enough that patients' cancer can grow while they wait.
Updated May 30
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
